BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18608207)

  • 1. Whole body radiography for bone survey screening of cancer and myeloma patients.
    Mulligan M; Smith S; Talmi D
    Cancer Invest; 2008 Nov; 26(9):916-22. PubMed ID: 18608207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey.
    Princewill K; Kyere S; Awan O; Mulligan M
    Cancer Invest; 2013 Mar; 31(3):206-11. PubMed ID: 23406213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison between traditional skeletal radiography and total body bone scintigraphy in the diagnosis of multiple myeloma].
    Scutellari PN; Spanedda R; Feggi LM; Calzolari F; Cervi PM
    Radiol Med; 1984 May; 70(5):271-6. PubMed ID: 6531460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could full-body digital X-ray (LODOX-Statscan) screening in trauma challenge conventional radiography?
    Deyle S; Wagner A; Benneker LM; Jeger V; Eggli S; Bonel HM; Zimmermann H; Exadaktylos AK
    J Trauma; 2009 Feb; 66(2):418-22. PubMed ID: 19204516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bone scintigraphy and radiography in multiple myeloma.
    Woolfenden JM; Pitt MJ; Durie BG; Moon TE
    Radiology; 1980 Mar; 134(3):723-8. PubMed ID: 7355226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole body bone scintigraphy compared to conventional radiography in detecting bone lesions in multiple myeloma.
    Deding A; Ingeberg S; Jørgensen PS
    Dan Med Bull; 1981 Oct; 28(5):207-9. PubMed ID: 7327007
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
    Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
    Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.
    Horger M; Claussen CD; Bross-Bach U; Vonthein R; Trabold T; Heuschmid M; Pfannenberg C
    Eur J Radiol; 2005 May; 54(2):289-97. PubMed ID: 15837412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
    World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiography and bone scintigraphy in multiple myeloma: a comparative analysis.
    Ludwig H; Kumpan W; Sinzinger H
    Br J Radiol; 1982 Mar; 55(651):173-81. PubMed ID: 7066617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
    Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphic evaluation of the skeleton in multiple myeloma.
    Wahner HW; Kyle RA; Beabout JW
    Mayo Clin Proc; 1980 Dec; 55(12):739-46. PubMed ID: 7218877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone disease in multiple myeloma. A study of 237 cases].
    Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
    Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology].
    Feggi LM; Spanedda R; Scutellari PN; Prandini N; Gennari M; Orzincolo C; Scapoli GL; Bagni B
    Radiol Med; 1988 Oct; 76(4):311-5. PubMed ID: 3141987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body (18)F-FDG PET identifies high-risk myeloma.
    Durie BG; Waxman AD; D'Agnolo A; Williams CM
    J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of FDG PET in the assessment of patients with multiple myeloma.
    Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
    AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose biplanar skeletal survey versus digital skeletal survey in multiple myeloma.
    Boutry N; Dutouquet B; Leleu X; Vieillard MH; Duhamel A; Cotten A
    Eur Radiol; 2013 Aug; 23(8):2236-45. PubMed ID: 23512194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.
    Shortt CP; Gleeson TG; Breen KA; McHugh J; O'Connell MJ; O'Gorman PJ; Eustace SJ
    AJR Am J Roentgenol; 2009 Apr; 192(4):980-6. PubMed ID: 19304704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does magnetic resonance imaging give value-added than bone scintigraphy in the detection of vertebral metastasis?
    Chiewvit P; Danchaivijitr N; Sirivitmaitrie K; Chiewvit S; Thephamongkhol K
    J Med Assoc Thai; 2009 Jun; 92(6):818-29. PubMed ID: 19530588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the new Statscan radiography device for ventriculoperitoneal shunt assessment.
    Fathi AR; Mariani L; Szucs Farkas Z; Exadaktylos AK; Bonel HM
    AJR Am J Roentgenol; 2011 Mar; 196(3):W285-9. PubMed ID: 21343476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.